Insulet (PODD) Operating Expenses (2010 - 2026)

Insulet's Operating Expenses history runs 17 years deep, the most recent figure standing at $406.9 million for Q1 2026.

• Quarterly Operating Expenses rose 27.04% year-over-year to $406.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 billion (up 28.62% YoY) and the FY2025 annual result came in at $1.5 billion, up 28.97% from the prior year.
• Operating Expenses was $406.9 million for Q1 2026 at Insulet, down from $422.3 million in the prior quarter.
• Across five years, Operating Expenses topped out at $422.3 million in Q4 2025 and bottomed at $171.8 million in Q1 2022.
• A 5-year average of $277.5 million and a median of $254.7 million in 2023 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2022 — Operating Expenses soared 441.15% — and 2023, when it gained 7.74%.
• Insulet's Operating Expenses stood at $193.8 million in 2022, then jumped by 31.42% to $254.7 million in 2023, then rose by 26.23% to $321.5 million in 2024, then jumped by 31.35% to $422.3 million in 2025, then declined by 3.65% to $406.9 million in 2026.
• Business Quant data shows PODD's Operating Expenses at $406.9 million in Q1 2026, $422.3 million in Q4 2025, and $392.4 million in Q3 2025.